Monoclonal Antibodies Incsaid a a district court has decided to grant a motion byHybritech Inc, a unit of Eli Lilly and Co &lt;LLY>, preventing thesale of certain Monoclonal products.    The products, including Ovustick Self-Test and Advance, apregnancy test, account for 80 pct of Monoclonal sales, thebiotechnology company said.    The products are made by Monoclonal and marketed by OrthoPharmaceutical Corp, a unit of Johnson and Johnson &lt;JNJ>.    The products were named in lawsuits dating back to 1984,the company said.    Documents will be filed within 10 days for the judge toissue a preliminary injunction, which should become effectiveafter the filing, the company said.    The company is evaluating the impact of the injunction onits operations. "While we're of course extremely disappointedby the court's decision, we will continue development effortson products not subject to a potential infringement ruling,particularly diagnostic tests for drugs of abuse and sexuallytransmitted diseases," the company said in a statement.    The company hopes to have the new products available forsale late this year or early next year, it said.    In the meantime, it will focus efforts on marketingproducts not affected by the injunction and designing otherproducts, it added. Reuter&#3;